David Levy, Ouriel Saura, Manuela Lucenteforte, Elena Collado Lledó, Pierre Demondion, Nadjib Hammoudi, Benjamin Assouline, Matthieu Petit, Melchior Gautier, Lucie Le Fevre, Marc Pineton de Chambrun, Guillaume Coutance, Elodie Berg, Juliette Chommeloux, Matthieu Schmidt, Charles-Edouard Luyt, Guillaume Lebreton, Pascal Leprince, Guillaume Hekimian, Alain Combes
BACKGROUND: Right ventricular failure (RVF) is a major cause of early mortality after heart transplantation (HT). Isoproterenol has chronotropic, inotropic, and vasodilatory properties which might improve right ventricle function in this setting. We aimed to investigate the hemodynamic effects of isoproterenol on patients with post-HT RVF. METHODS: We conducted a one-year retrospective observational study including patients receiving isoproterenol and dobutamine for early RVF after HT...
May 3, 2024: American Journal of Physiology. Heart and Circulatory Physiology